PGI21 a Comparison of the Cost-Effectiveness of Fidaxomicin, Metronidazole, and Vancomycin, in the Treatment of Clostridium Difficile-Associated Disease
Jun 1, 2012, 00:00 AM
10.1016/j.jval.2012.03.748
https://www.valueinhealthjournal.com/article/S1098-3015(12)00813-3/fulltext
Section Title :
Gastrointestinal Disorders
Section Order :
222
First Page :
A138
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)00813-3&doi=10.1016/j.jval.2012.03.748